With the analysis among 263 patents, we discovered top 26 key players by total patent application. Glaxo Group Ltd., Merck Sharp & Dohme Corp., MSD R&D (China) Co. Ltd. are dominant in this area. They take 82.89% of the total patent filing.
Hounslow, United Kingdom
Patent: 178
New Jersey, United States
Patent: 21
Beijing Shi, China
Patent: 19
Emilia-Romagna, Italy
Patent: 8
New Jersey, United States
Patent: 7
Pennsylvania, United States
Patent: 6
California, United States
Patent: 5
California, United States
Patent: 4
Nordrhein-Westfalen, Germany
Patent: 3
With the analysis among 1 patents, we discovered top 1 start-ups by total patent application.
California, United States
Patent: 1
With the analysis among related 118 patents applied in the last 5 years. We discover 13 most active companies in this area. The fast-growing Vanderbilt University, Neurocrine Biosciences, Inc., Merck Sharp & Dohme Corp. take 91.53% of patent filing during this period.
Tennessee, United States
Patent: 99
California, United States
Patent: 5
New Jersey, United States
Patent: 4
Beijing Shi, China
Patent: 3
California, United States
Patent: 2
California, United States
Patent: 1
Manitoba, Canada
Patent: 1
California, United States
Patent: 1
Brussels Hoofdstedelijk Gewest, Belgium
Patent: 1
With the analysis among related 118 patents in last 5 years, we discover 5 new entrants. Neurocrine Biosciences, Inc., Pipeline Therapeutics, Inc., Vrije Universiteit Brussel are the most active new entrants in this area.
California, United States
Patent: 5
California, United States
Patent: 1
Brussels Hoofdstedelijk Gewest, Belgium
Patent: 1
Hovedstaden, Denmark
Patent: 1
With the analysis among 187 patents, we discovered top 5 universities and scientific research institutions by total patent application. Vanderbilt University, University of Manitoba, Vrije Universiteit Brussel are dominant in this area. They take 98.93% of the total patent filing.
Tennessee, United States
Patent: 173
Manitoba, Canada
Patent: 9
Brussels Hoofdstedelijk Gewest, Belgium
Patent: 1